Quick summary: DCA Vantage® HbA1c (DX Claim). Reason: Health product recall. Category: Health products. Date: 2026-07-22.
DCA Vantage® HbA1c (DX Claim)
2026-07-22
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: DCA Vantage® HbA1c (DX Claim). Reason: Health product recall. Category: Health products. Date: 2026-07-22.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Siemens Healthineers has confirmed through customer complaint investigation and internal testing that delamination of the buffer pull-tab may occur in a small subset of cartridges. Delamination occurs when bonded material layers within the pull-tab separate, preventing full release of the buffer solution into the reaction chamber and reducing the reagent volume available for analysis.When delamination occurs, it may result in falsely low (negatively biased) HbA1c results or instrument-generated error codes that prevent completion of the test. The issue observed in approximately 0.07-0.5% of cartridges in these lots. The majority of the cartridges in these lots continue to perform as intended.
What you should do
- Contact the manufacturer if you require additional information.
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.